PRKD1 and diabetic cardiomyopathy: PKD activation also mitigated lipid accumulation, insulin resistance and maladaptive remodeling in diabetic cardiomyopathy (Dirkx et al., 2014) although other groups found PKD inhibition enhanced cardiac function in that setting (Liu et al., 2015; Venardos et al., 2015).